Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neximmune Inc NEXI

NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates include NEXI-001 in acute myeloid leukemia (AML); NEXI-002 in multiple myeloma (MM), and NEXI-003, a solid tumor product candidate for Human... see more

Bullboard (PINL:NEXI)

View:
Post by MikeTesteron Aug 03, 2024 2:29pm

NexImmune, Inc. (NASDAQ:NEXI): A Promising Biotech Poised fo

https://beyondspx.com/2024/08/03/neximmune-inc-nasdaqnexi-a-promising-biotech-poised-for-transformation/
Post by whytestockson Feb 06, 2024 9:00pm

NexImmune Announces Closing of $3.67 Million Registered Dire

BREAKING NEWS: $NEXI NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. ...more  
Post by whytestockson Feb 02, 2024 6:15pm

NexImmune Announces $3.67 Million Registered Direct Offering

Just In: $NEXI NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGAITHERSBURG, Md., Feb. 02, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology ...more  
Comment by Iseneschalon Feb 02, 2024 3:11pm

RE:NEXI....hard to keep on top of things....

the previous one was for raising upto 50M, today it is a direct offering where they offered unregistered warrants which will bring the price down because as soon those get exercised, company has to ...more  
Post by Iseneschalon Feb 02, 2024 3:10pm

NEXI....hard to keep on top of things....

The 8K is about terminating an old agreement date June 2022 between Cantor and Nexi to raise upto 50 M cash , so the company is not liquidating
Comment by Iseneschalon Feb 02, 2024 2:45pm

RE:NEXI....The P.O is terminated

Inline XBRL Viewer (sec.gov)
Comment by Iseneschalon Feb 02, 2024 2:09pm

RE:NEXI.....please not all at once....Sub $13 now....

Well here it is Flolks ...The Gomer Pyle moment P.O announce...just now Hymen Slimers....LoL Very sneaky
Post by Nibinatoron Jan 30, 2024 5:27pm

MARK

Oh by the way have you remarked what microsoft lended to REMARK
Post by Iseneschalon Jan 30, 2024 3:38pm

NEXI.....please not all at once....Sub $13 now....

as predicted Wait for the announcement It's going to be a "Gomer Pyle" moment ; )
Post by Iseneschalon Jan 30, 2024 3:10pm

NEXI....sub $15...next support is $13

I tell ya...this is going to surprise a whole lot of people Total cr8p
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities